CoChat

Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis: Serum myostatin in haemodialysis

Han, Der-Sheng, Chen, Yung-Ming, Lin, Sen-Yung, Chang, Hao-Hsiang, Huang, Tao-Min, Chi, Yu-Chiao, Yang, Wei-Shiung · 2011 · Clinical Endocrinology
Cited by 83

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Myostatin, a negative regulator of skeletal muscle growth, may modulate grip strength, an indicator of muscle function. Its serum levels could be modulated by maintenance haemodialysis (MHD). DESIGN: A descriptive cross-sectional study. PATIENTS: Forty-one normal controls and 60 MHD patients using different dialyzers at a medical centre. MEASUREMENTS: The grip strength of the dominant hand, body composition, and the predialysis and postdialysis serum myostatin and IGF-1 levels were measured. RESULTS: The MHD patients had lower body mass index, IGF-1 level, and grip strength than the normal controls. The patients using the high-flux dialyzer had better grip strength than those using the low-flux dialyzer (25·5 vs 19·2 kg). The predialysis myostatin level was higher in low-flux dialyzer than high-flux dialyzer (31·0 vs 18·5 μg/ml). Interestingly, the high-flux dialyzer reduced the serum myostatin by 36%, whereas low-flux dialyzer increased it by 25%. The myostatin was inversely related to age and the use of high-flux dialyzer. Furthermore, the grip strength was negatively related to age, female gender, muscle mass, myostatin levels and haemodialysis, but positively to the use of high-flux dialyzer in linear regression. The risk of low grip strength was 7·6 times higher in those with higher serum myostatin with the adjustment of age, gender, muscle mass, haemodialysis and mode of dialysis in a logistic regression. CONCLUSIONS: The mode of dialyzer modulates the blood levels of myostatin. Higher myostatin is associated with lower muscle function. The use of myostatin assay in various clinical settings merits further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2011.04120.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 33

  1. Zimmers, 2002, Induction of cachexia in mice by systemically administered myostatin, Science, 296, 1486, 10.1126/science.1069525 · DOI · Paper page
  2. Seibert, 2001, Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women’s Health and Aging Study II Cohort, Journal of the American Geriatrics Society, 49, 1093, 10.1046/j.1532-5415.2001.49214.x · DOI · Paper page
  3. Sharma, 2001, Myostatin in muscle growth and repair, Exercise and Sport Sciences Reviews, 29, 155, 10.1097/00003677-200110000-00004 · DOI · Paper page
  4. Shyu, 2005, Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes, Cardiovascular Research, 68, 405, 10.1016/j.cardiores.2005.06.028 · DOI
  5. Gaussin, 2005, Myostatin, the cardiac chalone of insulin-like growth factor-1, Cardiovascular Research, 68, 347, 10.1016/j.cardiores.2005.09.007 · DOI
  6. Rios, 2003, Differential response to exogenous and endogenous myostatin in myoblasts suggests that myostatin acts as an autocrine factor in vivo, Endocrinology, 145, 2795, 10.1210/en.2003-1166 · DOI · Paper page
  7. Du, 2005, Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions, European Journal of Clinical Investigation, 35, 157, 10.1111/j.1365-2362.2005.01473.x · DOI
  8. Mak, 2006, Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation, Kidney International, 70, 410, 10.1038/sj.ki.5001622 · DOI
  9. Heimbürger, 2000, Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy, American Journal of Kidney Diseases, 36, 1213, 10.1053/ajkd.2000.19837 · DOI · Paper page
  10. Rockel, 1986, Permeability and secondary membrane formation of a high flux polysulfone hemofilter, Kidney International, 30, 429, 10.1038/ki.1986.202 · doi:10.1038/ki.1986.202
  11. Okamoto, 2009, Home-based resistance training improves arterial stiffness in healthy premenopausal women, European Journal of Applied Physiology, 107, 113, 10.1007/s00421-009-1102-x · DOI
  12. Kotanko, 2008, Current state of bioimpedance technologies in dialysis, Nephrology Dialysis and Transplantation, 23, 808, 10.1093/ndt/gfm889 · DOI
  13. Mathiowetz, 1985, Grip and pinch strength: normative data for adults, Archives of Physical Medicine and Rehabilitation, 66, 69
  14. Cheung, 2003, Effects of high-flux haemodialysis on clinical outcomes: results of the HEMO Study, Journal of the American Society of Nephrology, 14, 3251, 10.1097/01.ASN.0000096373.13406.94 · DOI · Paper page
  15. DeSilva, 2003, Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules, Pharmaceutical Research, 20, 1885, 10.1023/B:PHAM.0000003390.51761.3d · DOI · Paper page
  16. Xing, 2007, Characterization of amphioxus GDF8/11 gene, an archetype of vertebrate MSTN and GDF11, Development Genes and Evolution, 217, 549, 10.1007/s00427-007-0162-3 · DOI
  17. Jones, 1994, Extension of the four-parameter logistic model for ELISA to multianalyte analysis, Journal of Immunological Methods, 177, 1, 10.1016/0022-1759(94)90136-8 · doi:10.1016/0022-1759(94)90136-8
  18. Bergström, 1987, No change in corrected β2-microglobulin concentration after cuprophane haemodialysis, The Lancet, 329, 628, 10.1016/S0140-6736(87)90266-2 · doi:10.1016/s0140-6736(87)90266-2
  19. Kloppenburg, 1999, Assessing dialysis adequacy and dietary intake in the individual haemodialysis patient, Kidney International, 55, 1961, 10.1046/j.1523-1755.1999.00412.x · DOI
  20. Ma, 2003, Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression, American Journal of Physiology Endocrinology Metabolism, 285, E363, 10.1152/ajpendo.00487.2002 · DOI · Paper page
  21. Hosoyama, 2009, Long term adrenal insufficiency induces skeletal muscle atrophy and increases the serum levels of active form myostatin in rat serum, Zoological Science, 22, 229, 10.2108/zsj.22.229 · DOI
  22. Lakshman, 2009, Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration, Molecular and Cellular Endocrinology, 302, 26, 10.1016/j.mce.2008.12.019 · DOI
  23. Oreopoulos, 2010, Association between direct measures of body composition and prognostic factors in chronic heart failure, Mayo Clinic Proceedings, 85, 609, 10.4065/mcp.2010.0103 · DOI · Paper page
  24. Shephard, 1991, Handgrip dynamometry, Cybex measurements and lean mass as markers of the ageing of muscle function, British Journal of Sports Medicine, 25, 204, 10.1136/bjsm.25.4.204 · DOI
  25. Maughan, 1984, The influence of variations in muscle fibre composition on muscle strength and cross-sectional area in untrained males, The Journal of Physiology, 351, 299, 10.1113/jphysiol.1984.sp015246 · DOI · Paper page
  26. Kopple, 2007, Exercise in maintenance haemodialysis patients induces transcriptional changes in genes favoring anabolic muscle, Journal of the American Society of Nephrology, 18, 2975, 10.1681/ASN.2006070794 · DOI · Paper page
  27. Sun, 2006, Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia, Kidney International, 70, 453, 10.1038/sj.ki.5001532 · DOI
  28. Kaysen, 2004, Inflammation: cause of vascular disease and malnutrition in dialysis patients, Seminars in Nephrology, 24, 431, 10.1016/j.semnephrol.2004.06.009 · DOI
  29. Guernec, 2004, Nutrient supply enhances both IGF-I and MSTN mRNA levels in chicken skeletal muscle, Domestic Animal Endocrinology, 26, 143, 10.1016/j.domaniend.2003.10.001 · DOI
  30. Grimberg, 2000, Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis, Journal of Cellular Physiology, 183, 1, 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J · DOI · Paper page
  31. Baxter, 1994, Insulin-like growth factor binding proteins in the human circulation: a review, Hormone Research, 42, 140, 10.1159/000184186 · DOI · Paper page
  32. Qureshi, 2002, Inflammation, malnutrition, and cardiac disease as predictors of mortality in haemodialysis patients, Journal of the American Society of Nephrology, 13, S28, 10.1681/ASN.V13suppl_1s28 · DOI · Paper page
  33. Clark, 1999, Quantifying the effect of changes in the haemodialysis prescription on effective solute removal with a mathematical model, Journal of the American Society of Nephrology, 10, 601, 10.1681/ASN.V103601 · doi:10.1681/asn.v103601

Cited by

See all 83

Metadata

Authors
Han, D.-S., Chen, Y.-M., Lin, S.-Y., Chang, H.-H., Huang, T.-M., Chi, Y.-C., & Yang, W.-S.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2011-11-09
Volume
75
Issue
6
Pages
857-863
ISSN
0300-0664 (ISSN-L)
OpenAlex
W1551939606
Cited by
83
References
6
FWCI
2.63
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1392 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis: Serum myostatin in haemodialysis. https://app.cochat.ai/papers/10.1111/j.1365-2265.2011.04120.x
The paper
Han, D.-S., Chen, Y.-M., Lin, S.-Y., Chang, H.-H., Huang, T.-M., Chi, Y.-C., & Yang, W.-S. (2011). Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis: Serum myostatin in haemodialysis. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2011.04120.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.